LXRX
LXRX
NASDAQ · Pharmaceuticals

Lexicon Pharmaceuticals Inc

$2.31
+0.09 (+4.05%)
As of Jun 25, 2:37 PM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 8 73%
Hold 3 27%
Sell 0 0%
Price Target
Analyst Price Target +677.9% upside
Low Target $15.16
Average Target $17.97
High Target $22.64
Current Price $2.31
Current
$2.31
Target
$17.97
$15.16 $17.97 avg $22.64
Scenario Analysis
Bear Case
$15.16
556.3%
Low target
Base Case
$17.97
+677.9%
Avg target
Bull Case
$22.64
+880.1%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$2.53
-8.7% from high
52-Week Low
$0.70
+228.6% from low
Target vs 52W High
$17.97
+610.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.0%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.0%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +43.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +215.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +169.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.7%